RT Journal Article
SR Electronic
T1 Lower probability and shorter duration of infections after Covid-19 vaccine correlate with anti-SARS-CoV-2 circulating IgGs
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.24.21263978
DO 10.1101/2021.09.24.21263978
A1 Ronchini, Chiara
A1 Gandini, Sara
A1 Pasqualato, Sebastiano
A1 Mazzarella, Luca
A1 Facciotti, Federica
A1 Mapelli, Marina
A1 ,
A1 Frige’, Gianmaria
A1 Passerini, Rita
A1 Pase, Luca
A1 Capizzi, Silvio
A1 Mastrilli, Fabrizio
A1 Orecchia, Roberto
A1 Natoli, Gioacchino
A1 Pelicci, Pier Giuseppe
YR 2021
UL http://medrxiv.org/content/early/2021/09/30/2021.09.24.21263978.abstract
AB The correlation between immune responses and protection from SARS-CoV-2 infections and its duration remains unclear. We performed a sanitary surveillance at the European Institute of Oncology (IEO) in Milan over a 17 months period. Pre-vaccination, in 1,493 participants, we scored 266 infections (17.8%) and 8 possible reinfections (3%). Post-vaccination, we identified 30 infections in 2,029 vaccinated individuals (1.5%). We report that the probability of infection post-vaccination is i) significantly lower compared to natural infection, ii) associated with a significantly shorter median duration of infection than that of first infection and reinfection, iii) anticorrelated with circulating antibody levels.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Fondazione Europea Guido Venosta, National Instruments Corporation, Ralph Lauren and Fondo MFS.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the IRB of the European Institute of OncologyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.